{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:10:48Z","timestamp":1792188648526,"version":"4.4.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1038\/s41374-021-00685-4","type":"journal-article","created":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T14:02:41Z","timestamp":1635602561000},"page":"102-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Synergistic upregulation of ADAMTS4 (aggrecanase-1) by cytokines and its suppression in knee osteoarthritic synovial fibroblasts"],"prefix":"10.1016","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0808-2691","authenticated-orcid":false,"given":"Mehmet Zeynel","family":"Cilek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"de Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Shiozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiho","family":"Yoshinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Miyamae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Chijiiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satsuki","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneaki","family":"Ishijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9208-4755","authenticated-orcid":false,"given":"Yasunori","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41374-021-00685-4_bib1","series-title":"Kelley and Firestein's Textbook of Rheumatology","first-page":"106","article-title":"Proteinases and matrix degradation","author":"Okada","year":"2017"},{"key":"10.1038\/s41374-021-00685-4_bib2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/ncprheum0841","article-title":"Drug insight: aggrecanases as therapeutic targets for osteoarthritis","volume":"4","author":"Fosang","year":"2008","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"10.1038\/s41374-021-00685-4_bib3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1440-1827.2010.02547.x","article-title":"Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases","volume":"60","author":"Shiomi","year":"2010","journal-title":"Pathol. Int."},{"key":"10.1038\/s41374-021-00685-4_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/BJ20040424","article-title":"The ADAMTS metalloproteinases","volume":"386","author":"Porter","year":"2005","journal-title":"Biochem. J."},{"key":"10.1038\/s41374-021-00685-4_bib5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/ar1783","article-title":"ADAMTS proteinases: a multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis","volume":"7","author":"Jones","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1038\/s41374-021-00685-4_bib6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bbagen.2006.01.013","article-title":"Glycosaminoglycan-binding properties and aggrecanase activities of truncated ADAMTSs: comparative analyses with ADAMTS-5, -9, -16 and -18","volume":"1760","author":"Zeng","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1038\/s41374-021-00685-4_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/138920108783497622","article-title":"Will the real aggrecanase(s) step up: evaluating the criteria that define aggrecanase activity in osteoarthritis","volume":"9","author":"Tortorella","year":"2008","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1038\/s41374-021-00685-4_bib8","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nature03369","article-title":"Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis","volume":"434","author":"Glasson","year":"2005","journal-title":"Nature"},{"key":"10.1038\/s41374-021-00685-4_bib9","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature03417","article-title":"ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro","volume":"434","author":"Stanton","year":"2005","journal-title":"Nature"},{"key":"10.1038\/s41374-021-00685-4_bib10","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/art.1780301001","article-title":"Arthroscopic and immunohistologic characterization of knee joint synovitis in osteoarthritis","volume":"30","author":"Lindblad","year":"1987","journal-title":"Arthritis Rheum."},{"key":"10.1038\/s41374-021-00685-4_bib11","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrrheum.2010.159","article-title":"The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis","volume":"6","author":"Sellam","year":"2010","journal-title":"Nature Rev. Rheumatol."},{"key":"10.1038\/s41374-021-00685-4_bib12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.joca.2005.01.005","article-title":"Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis\u2013results of a 1 year longitudinal arthroscopic study in 422 patients","volume":"13","author":"Ayral","year":"2005","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1038\/s41374-021-00685-4_bib13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.joca.2012.09.012","article-title":"Osteoarthritis as a disease of mechanics","volume":"21","author":"Felson","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1038\/s41374-021-00685-4_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/art.40660","article-title":"Association of changes in effusion-synovitis with progression of cartilage damage over eighteen months in patients with osteoarthritis and meniscal tear","volume":"71","author":"MacFarlane","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1038\/s41374-021-00685-4_bib15","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.joca.2015.09.013","article-title":"Synovitis and the risk of knee osteoarthritis: the MOST Study","volume":"24","author":"Felson","year":"2016","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1038\/s41374-021-00685-4_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13075-017-1229-9","article-title":"Synovitis in osteoarthritis: current understanding with therapeutic implications","volume":"19","author":"Mathiessen","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1038\/s41374-021-00685-4_bib17","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.ajpath.2016.05.017","article-title":"Healthy and osteoarthritic synovial fibroblasts produce a disintegrin and metalloproteinase with thrombospondin motifs 4, 5, 7, and 12: Induction by IL-1beta and fibronectin and contribution to cartilage damage","volume":"186","author":"Perez-Garcia","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1038\/s41374-021-00685-4_bib18","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1046\/j.1432-1327.2001.01990.x","article-title":"Expression and activity of ADAMTS-5 in synovium","volume":"268","author":"Vankemmelbeke","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1038\/s41374-021-00685-4_bib19","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.joca.2018.12.012","article-title":"Molecular expression patterns in the synovium and their association with advanced symptomatic knee osteoarthritis","volume":"27","author":"Wyatt","year":"2019","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1038\/s41374-021-00685-4_bib20","first-page":"680","article-title":"Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium","volume":"66","author":"Okada","year":"1992","journal-title":"Lab. Invest."},{"key":"10.1038\/s41374-021-00685-4_bib21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/ard.59.6.455","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis","volume":"59","author":"Yoshihara","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"10.1038\/s41374-021-00685-4_bib22","doi-asserted-by":"crossref","first-page":"R124","DOI":"10.1186\/ar2013","article-title":"Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage","volume":"8","author":"Davidson","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1038\/s41374-021-00685-4_bib23","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.4049\/jimmunol.168.3.1405","article-title":"Expression and regulation of aggrecanase in arthritis: the role of TGF-beta","volume":"168","author":"Yamanishi","year":"2002","journal-title":"J. Immunol."},{"key":"10.1038\/s41374-021-00685-4_bib24","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/ard.2007.086884","article-title":"Hyaluronan inhibits expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic chondrocytes","volume":"68","author":"Yatabe","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1038\/s41374-021-00685-4_bib25","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa0706290","article-title":"Adalimumab with or without methotrexate in juvenile rheumatoid arthritis","volume":"359","author":"Lovell","year":"2008","journal-title":"N. Engl J. Med."},{"key":"10.1038\/s41374-021-00685-4_bib26","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","article-title":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis","volume":"367","author":"De Benedetti","year":"2012","journal-title":"N. Engl J. Med."},{"key":"10.1038\/s41374-021-00685-4_bib27","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780290816","article-title":"Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association","volume":"29","author":"Altman","year":"1986","journal-title":"Arthritis Rheum."},{"key":"10.1038\/s41374-021-00685-4_bib28","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/art.39078","article-title":"CCN1 (Cyr61) is overexpressed in human osteoarthritic cartilage and inhibits ADAMTS-4 (aggrecanase 1) activity","volume":"67","author":"Chijiiwa","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1038\/s41374-021-00685-4_bib29","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1440-1827.2007.02167.x","article-title":"Expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic cartilage","volume":"57","author":"Naito","year":"2007","journal-title":"Pathol. Int."},{"key":"10.1038\/s41374-021-00685-4_bib30","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/1529-0131(200004)43:4<812::AID-ANR11>3.0.CO;2-Y","article-title":"Production of tissue inhibitor of metalloproteinases 3 is selectively enhanced by calcium pentosan polysulfate in human rheumatoid synovial fibroblasts","volume":"43","author":"Takizawa","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1038\/s41374-021-00685-4_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082282","article-title":"Onset and progression of human osteoarthritis\u2014can growth factors, inflammatory cytokines, or differential miRNA expression concomitantly induce proliferation, ECM degradation, and inflammation in articular cartilage?","volume":"19","author":"Boehme","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1038\/s41374-021-00685-4_bib32","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.joca.2015.04.019","article-title":"Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is increased in osteoarthritis and regulates chondrocyte catabolic and anabolic activities","volume":"23","author":"Long","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1038\/s41374-021-00685-4_bib33","doi-asserted-by":"crossref","first-page":"32483","DOI":"10.1074\/jbc.M314216200","article-title":"ADAMTS4 (aggrecanase-1) interaction with the C-terminal domain of fibronectin inhibits proteolysis of aggrecan","volume":"279","author":"Hashimoto","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1038\/s41374-021-00685-4_bib34","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.4049\/jimmunol.0803544","article-title":"Adaptor proteins and Ras synergistically regulate IL-1-induced ADAMTS-4 expression in human chondrocytes","volume":"182","author":"Ahmad","year":"2009","journal-title":"J. Immunol."},{"key":"10.1038\/s41374-021-00685-4_bib35","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.ajpath.2013.02.037","article-title":"Inflammatory cytokines associated with degenerative disc disease control aggrecanase-1 (ADAMTS-4) expression in nucleus pulposus cells through MAPK and NF-kappaB","volume":"182","author":"Tian","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1038\/s41374-021-00685-4_bib36","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.bbrc.2013.02.043","article-title":"Mechanisms involved in suppression of ADAMTS4 expression in synoviocytes by high molecular weight hyaluronic acid","volume":"432","author":"Kataoka","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1038\/s41374-021-00685-4_bib37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12013-014-0417-3","article-title":"The changes in the expression of NF-KB in a degenerative human intervertebral disc model","volume":"72","author":"Sun","year":"2015","journal-title":"Cell. Biochem. Biophys."},{"key":"10.1038\/s41374-021-00685-4_bib38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/ijms18010205","article-title":"post-translational nodifications of the TAK1-TAB complex","volume":"18","author":"Hirata","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1038\/s41374-021-00685-4_bib39","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/art.21010","article-title":"ADAMTS-9 is synergistically induced by interleukin-1beta and tumor necrosis factor alpha in OUMS-27 chondrosarcoma cells and in human chondrocytes","volume":"52","author":"Demircan","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1038\/s41374-021-00685-4_bib40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/art.11433","article-title":"Expression profiling of metalloproteinases and their inhibitors in cartilage","volume":"50","author":"Kevorkian","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1038\/s41374-021-00685-4_bib41","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.matbio.2008.02.002","article-title":"The regulation of aggrecanase ADAMTS-4 expression in human Achilles tendon and tendon-derived cells","volume":"27","author":"Corps","year":"2008","journal-title":"Matrix Biol."},{"key":"10.1038\/s41374-021-00685-4_bib42","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.joca.2003.11.009","article-title":"Effects of transforming growth factor-beta on aggrecanase production and proteoglycan degradation by human chondrocytes in vitro","volume":"12","author":"Moulharat","year":"2004","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1038\/s41374-021-00685-4_bib43","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/art.10212","article-title":"The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: A time-course study using real-time quantitative reverse transcription-polymerase chain reaction","volume":"46","author":"Koshy","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1038\/s41374-021-00685-4_bib44","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/1756-185X.12431","article-title":"Pro-inflammatory IL-1beta and\/or TNF-alpha up-regulate matrix metalloproteases-1 and -3 mRNA in chondrocyte subpopulations potentially pathogenic in osteoarthritis: in situ hybridization studies on a single cell level","volume":"19","author":"Kunisch","year":"2016","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1038\/s41374-021-00685-4_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/cyto.2001.0950","article-title":"Modulation of the expression of matrix metalloproteinase and tissue inhibitors of metalloproteinases by TGF-beta1 and IGF-1 in primary human articular and bovine nasal chondrocytes stimulated with TNF-alpha","volume":"16","author":"Hui","year":"2001","journal-title":"Cytokine"},{"key":"10.1038\/s41374-021-00685-4_bib46","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.joca.2004.12.010","article-title":"Elucidation of IL-1\/TGF-beta interactions in mouse chondrocyte cell line by genome-wide gene expression","volume":"13","author":"Takahashi","year":"2005","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1038\/s41374-021-00685-4_bib47","doi-asserted-by":"crossref","first-page":"30226","DOI":"10.1074\/jbc.M005310200","article-title":"Tumor necrosis factor-alpha inhibits transforming growth factor-beta \/Smad signaling in human dermal fibroblasts via AP-1 activation","volume":"275","author":"Verrecchia","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1038\/s41374-021-00685-4_bib48","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/neuonc\/nou218","article-title":"Differential regulation of TGF-beta-induced, ALK-5-mediated VEGF release by SMAD2\/3 versus SMAD1\/5\/8 signaling in glioblastoma","volume":"17","author":"Seystahl","year":"2015","journal-title":"Neuro. Oncol."},{"key":"10.1038\/s41374-021-00685-4_bib49","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1073\/pnas.0700118104","article-title":"Dose-dependent cross-talk between the transforming growth factor-beta and interleukin-1 signaling pathways","volume":"104","author":"Lu","year":"2007","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"10.1038\/s41374-021-00685-4_bib50","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrrheum.2016.219","article-title":"The changing role of TGFbeta in healthy, ageing and osteoarthritic joints","volume":"13","author":"van der Kraan","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1038\/s41374-021-00685-4_bib51","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/jcp.1041520207","article-title":"Interleukin-1 beta induction of TNF-alpha gene expression: involvement of protein kinase C","volume":"152","author":"Bethea","year":"1992","journal-title":"J. Cell Physiol."},{"key":"10.1038\/s41374-021-00685-4_bib52","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.bmc.2016.11.034","article-title":"Studies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitors","volume":"25","author":"Tan","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1038\/s41374-021-00685-4_bib53","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.chembiol.2017.07.011","article-title":"Takinib, a selective TAK1 inhibitor, broadens the therapeutic efficacy of TNF-alpha inhibition for cancer and autoimmune disease","volume":"24","author":"Totzke","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"10.1038\/s41374-021-00685-4_bib54","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1158\/1078-0432.CCR-14-1380","article-title":"First-in-human dose study of the novel transforming growth factor-beta receptor I kinase inhibitor LY2157299 monohydrate in patients with advanced cancer and glioma","volume":"21","author":"Rodon","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1038\/s41374-021-00685-4_bib55","first-page":"4479","article-title":"Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway","volume":"9","author":"Herbertz","year":"2015","journal-title":"Drug. Des. Devel. Ther."}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41374-021-00685-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41374-021-00685-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722001106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722001106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41374-021-00685-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:24:58Z","timestamp":1758396298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722001106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0023683722001106"],"URL":"https:\/\/doi.org\/10.1038\/s41374-021-00685-4","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic upregulation of ADAMTS4 (aggrecanase-1) by cytokines and its suppression in knee osteoarthritic synovial fibroblasts","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41374-021-00685-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}